Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials'. Together they form a unique fingerprint.

Medicine & Life Sciences